Ocugen is spotlighting geographic atrophy, a severe retinal disease that can lead to vision loss, as it pushes awareness of retinal health. The update also rein
Ocugen is spotlighting geographic atrophy, a severe retinal disease that can lead to vision loss, as it pushes awareness of retinal health. The update also reinforces the biotech’s broader focus on gene therapy and rare-disease research.
Share this article
📚 More from Billy’s World
Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y •
YouTube: @BankingWithBilly